Riskpilot← Back to searchSign inGet full accessProbiomic ApS
APSActiveCVR 38844172Knud Højgaards Vej 9Activities of holding companies · NACE 6421Est. 20171 employees
Revenue 2025
DKK -222K
+47% vs 2024
EBITDA margin
190.1%
-178% vs 2024
Equity ratio
98.9%
Financial strength
Net profit 2025
DKK 2,6M
-12% vs 2024
| Revenue | DKK -222K | +47% |
| EBITDA | DKK -423K | -178% |
| Net profit | DKK 2,6M | -12% |
| Total assets | DKK 67M | -3% |
| Equity | DKK 66,2M | +2% |
| Employees | 1 | — |
Legal name
Probiomic ApS
CVR number
38844172
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
9. august 2017
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren
Company purpose
Selskabets formål er at udøve virksomhed som holdingselskab, samt at drive øvrig virksomhed i tilknytning hertil efter ledelsens skøn.
Address
Knud Højgaards Vej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -8 | -4 | -8 | -6 | -8 | -11 | -151 | -222 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -200 |
| EBITDA | -8 | -4 | -8 | -6 | -8 | -11 | -152 | -423 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -8 | -4 | -8 | -6 | -8 | -11 | -152 | -423 |
| Net financials | 0 | 0 | -2 | -100 | -0 | 74.155 | 3.871 | 3.725 |
| Profit before tax | -8 | -4 | -10 | -106 | -8 | 74.144 | 3.720 | 3.302 |
| Tax | -2 | -1 | 3 | -0 | -0 | -0 | 810 | 744 |
| Net profit | -6 | -3 | -12 | -106 | -8 | 74.144 | 2.909 | 2.558 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 44 | 41 | 136 | 29 | 28 | 74.172 | 68.818 | 67.000 |
| Equity | 44 | 41 | 29 | -78 | -85 | 74.059 | 64.684 | 66.242 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 107 | 107 | 113 | 113 | 4.135 | 759 |
| Total debt | 0 | 0 | 107 | 107 | 113 | 113 | 4.135 | 759 |
EBITDA margin
-42252800.0%
This company
15.8%
Market median
-267422885% vs market
20182025
Equity ratio
98.9%
This company
38.2%
Market median
+159% vs market
20182025
Return on equity
3.9%
This company
18.4%
Market median
-79% vs market
20182025
Net profit margin
255822900.0%
This company
8.1%
Market median
+3158307307% vs market
20182025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20182025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20182025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2017-08-09 – 2018-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Probiomic ApS 
Vitibiotech ApSBoard members of Probiomic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|